Statistics from Altmetric.com
Article usage
In this Issue
Advertisement
Related Articles
Cited By...
- A diabetic milieu increases cellular susceptibility to SARS-CoV-2 infections in engineered human kidney organoids and diabetic patients
- Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
- A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields
- FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant
- The Furin-S2' Site in Avian Coronavirus Plays a Key Role in Central Nervous System Damage Progression
- The PRRA Insert at the S1/S2 Site Modulates Cellular Tropism of SARS-CoV-2 and ACE2 Usage by the Closely Related Bat RaTG13
- On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?
- SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
- Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
- Large fluctuations of the fusion intermediate help SARS-CoV-2 capture host cell membranes
- Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin
- Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins
- Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
- Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
- Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
- SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
- Spike Protein of SARS-CoV-2 Activates Macrophages and Contributes to Induction of Acute Lung Inflammations in Mice
- The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo
- A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
- The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
- Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut
- Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19
- A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force